In an ongoing study to validate biomarkers for ovarian cancer, scientists collaborating with Ciphergen showed that when three newly discovered biomarkers were combined with a standard biomarker called CA 125, the test scored between .88 and .91 out of a perfect score of one, in terms of specificity and sensitivity.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.